INTRODUCTION
Transcutaneous bilirubinometry (TCB) was introduced into clinical practice in 1980 by Yamanouchi et al. 1 using a bilirubinometer developed by Minolta. This meter used a two-filter design to measure a ''hemoglobin-corrected yellow color.'' Because of the variability of the correlation of TCB readings and serum bilirubin concentration, the method has been most useful to help clinicians decide when serum bilirubin should be measured in jaundiced infants. Use of TCB has been shown to result in a significant decrease in the need for serum bilirubin determinations. 2 The variability of TCB is related primarily to other pigments in the skin, especially melanin and hemoglobin. 3 To decrease this variability, two new machines have been developed using reflectance data at multiple wavelengths. The ColorMate TLcÁBiliTest System (Chromatics Color Sciences International, New York, NY) requires an initial measurement shortly after birth, before the appearance of jaundice, and repeated subsequent measurements, all at multiple sites. 4 Because of these requirements, we did not test this instrument. The BiliCheck system (SpectR X , Norcross, GA) (referred to as the BC meter) requires five replicate measurements at one site to give a bilirubin estimate 5 in milligrams per deciliter (or micromoles per liter), which is based upon reflectance data analyzed at multiple wavelengths. The Jaundice Meter JM-102 (Minolta/Hill-Rom Air-Shields, Hatboro, PA) (referred to as the JM meter) is based upon two-wavelength analysis and gives a reflectance unit which must be correlated to serum bilirubin level values at the local institution. The purpose of this study was to compare these two instruments' accuracy for predicting serum bilirubin concentrations.
METHODS
The subjects were newborn infants in the normal newborn nursery of Pitt County Memorial Hospital (a unit of University Health Systems of Eastern Carolina). The study was approved by the University and Medical Center Institutional Review Board. After the physician ordered a total serum bilirubin (TSB) for clinical purposes, informed consent was obtained from a parent. Infants were excluded if they were receiving phototherapy. The TCB on the forehead was measured using the BC meter and the JM meter according to the manufacturer's instructions. Both instruments and supplies were provided without charge by the manufacturer. The order of use of the two instruments was randomized. Skin pigmentation of the forehead was also graded using a Skin Tone Chart provided by SpectR X . This chart gives four gradations of color, and we added intermediate gradations resulting in skin color scores 1 to 8, lightest to darkest. A blood sample for serum bilirubin determination was obtained by heel
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stick. These procedures were performed, all within 15 minutes, by one Medical Technologist. All infants were exposed to only the ambient fluorescent lighting in the nursery. Bilirubin concentration in the serum was determined in the clinical laboratory by the colorometric diazonium salt method using Olympus AU600 instrumentation (Olympus America, Melville, NY). Analysis of the data generated by the BC meter and TSB was by the method of Bland and Altman, 6 which compares the mean of two measurement methods to the difference in the measured values. For the JM meter values, which are read as reflectance units, a transformation was performed using linear regression (Transformation value=0.636ÂJM valueÀ1.652). In this case, the differences will be correlated with the mean. To avoid plotting this correlation, the differences (transformed JM meter readingÀTSB) are plotted against the JM meter values for comparison to the BlandAltman plot.
RESULTS
No parents refused participation in the study. One hundred one samples were obtained from 101 infants between January 9, 2000 and December 18, 2000. The distribution of reported race was 70 Caucasians, 21 African-Americans, 6 Hispanics, 4 Asians. The characteristics of the population were (mean±SD) birth weight, 3179±723 g; gestational age, 37.7±2.2 weeks; age at time of study, 50±18 hours; BC meter reading, 11.3±2.6; JM meter reading (not transformed), 19.9±2.8; TSB concentration, 11.0±2.6 mg/dl. The mode of the skin color was grade 1 (38 of 101).
To compare the effects of skin color on the variability of the meter readings, we fit regression models using the variables meter readings, skin color, and TSB (Table 1) . Skin color was defined as light (skin score readings 1 to 4, number=80) or dark (skin score readings 5 to 8, number=21). BC meter, most differences are within ±2 mg/dl. In spite of the advantage of the linear transformation of the JM meter readings, the JM meter readings' variability ( ±4 mg/dl) is almost twice that of the BC meter readings. With the BC meter readings, the skin color was not statistically significant (p=0.890) in predicting the TSB. With the JM meter readings, the skin color was statistically significant (p=0.002) in predicting the TSB.
DISCUSSION
These results demonstrate that the BC meter is superior to the JM meter in predicting TSB. This is probably related in part to the lack of effect of skin color on the BC meter readings. The BC meter uses multiple wavelengths to determine correction factors for the effect of melanin and hemoglobin on the bilirubin estimation. In the study of Bhutani et al., 5 there was also no effect of skin color as defined by race. Other studies have generally demonstrated that the JM meter readings are less accurate in babies with dark skin. 7 There are several applications for the TCB measurements. One is in a jaundiced infant to determine if serum bilirubin should be drawn to guide treatment. As an example, if we planned to use phototherapy on day 3 of life if the TSB was !15 mg/dl, and wanted to use TCB as a screening tool to decide when a blood sample should be drawn, we could base this decision on choosing a meter reading at the 5th percentile. Using the BC meter, we would need to draw a serum sample at a reading as low as 13.5 mg/dl. Using the JM meter, we would need to draw a serum sample on each baby whose TCB reading equivalent was 11.8 mg/dl.
Another application of TCB measurements is in predicting those infants requiring follow-up. To illustrate this, we have analyzed our data according to the hour-specific serum bilirubin nomogram of Bhutani et al. 8 The authors have demonstrated that infants with a serum bilirubin concentration above the 75th percentile on their nomogram ''may be considered to be at high risk for subsequent excessive hyperbilirubinemia,'' therefore requiring follow-up and that TCB may be used for the serum bilirubin estimation. 5 Their nomogram was based on universal serum bilirubin measurements at the time of metabolic screening. Approximately 50% of our population falls above the nomogram's 75th percentile because our screening was done only when there was clinical concern about the degree of visible jaundice. Using TSB values and age in hours, 49 patients were at higher risk, 49 were not. Three patients were excluded from these calculations because their readings were taken at less than 24 hours of age. The BC meter correctly identified 44 of 49 patients at higher risk (90%), whereas the JM meter correctly identified 38 (78%). The BC meter correctly identified 37 of 49 patients at lower risk (76%), whereas the JM meter correctly identified 33 (67%). The transformed JM meter values were obtained from the regression model for these data which provide estimates closer to the actual TSB values than would an objective transformation not obtained from the data. Using the JM meter, approximately 10% more babies will be erroneously judged to not require follow-up and about 10% more babies erroneously judged to require follow-up for hyperbilirubinemia. Because the higher-risk patients are clinically most important, we calculated how many more babies would require a TSB to enable the JM meter to equal the accuracy of the BC meter. The JM meter would require approximately 12% more infants having a follow-up to equal the performance of the BC meter.
The JM meter costs US$3995 and requires no additional supplies. The BiliCheck meter costs US$3900 and each patient use requires a BiliCal cap costing US$7. Both meters are relatively easy to use. If we consider screening 1000 babies a year, the cost, using the BC meter, is US$7000. Using the JM meter, the increased variability would require follow-up for consideration of jaundice of about 120 more infants than when using the BC meter.
Most interesting is the recent article by Rubaltelli et al., 9 which demonstrates that the BC meter is as accurate in predicting TSB determined by high-pressure liquid chromatography as are standard laboratory methods for determining TSB. Therefore, the BC meter is fully comparable to the current ''standard of care'' serum bilirubin measurement. If additional studies verify this finding, the BC meter may be used in both inpatient and outpatient services in place of routine TSB determinations.
